Filing Details

Accession Number:
0001209191-23-042270
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-14 16:34:31
Reporting Period:
2023-07-12
Accepted Time:
2023-07-14 16:34:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1308547 Dolby Laboratories Inc. DLB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1256708 Andrew Mark Sherman C/O Dolby Laboratories, Inc.
1275 Market Street
San Francisco CA 94103
Evp, Gen. Counsel & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2023-07-12 21,000 $62.32 77,730 No 4 M Direct
Class A Common Stock Disposition 2023-07-12 21,000 $89.00 56,730 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (right to buy) Disposition 2023-07-12 21,000 $0.00 21,000 $62.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,998 2024-12-15 No 4 M Direct
Footnotes
  1. Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest
  2. Shares include 356 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023.
  3. This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares.